NO961479L - Analgetisk middel og dets anvendelse - Google Patents

Analgetisk middel og dets anvendelse

Info

Publication number
NO961479L
NO961479L NO961479A NO961479A NO961479L NO 961479 L NO961479 L NO 961479L NO 961479 A NO961479 A NO 961479A NO 961479 A NO961479 A NO 961479A NO 961479 L NO961479 L NO 961479L
Authority
NO
Norway
Prior art keywords
analgesic agent
analgesic
agent
levobupivacaine
anaesthetic
Prior art date
Application number
NO961479A
Other languages
English (en)
Other versions
NO308508B1 (no
NO961479D0 (no
Inventor
Hazel Judith Bardsley
Robert William Gristwood
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO961479(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939321061A external-priority patent/GB9321061D0/en
Priority claimed from GB9408014A external-priority patent/GB9408014D0/en
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of NO961479D0 publication Critical patent/NO961479D0/no
Publication of NO961479L publication Critical patent/NO961479L/no
Publication of NO308508B1 publication Critical patent/NO308508B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO961479A 1993-10-13 1996-04-12 Anvendelse av levobupivacaine i enantiomert overskudd NO308508B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939321061A GB9321061D0 (en) 1993-10-13 1993-10-13 Analgestic agent and its use
GB9408014A GB9408014D0 (en) 1994-04-22 1994-04-22 Analgesic agent and its use
PCT/GB1994/002249 WO1995010277A1 (en) 1993-10-13 1994-10-13 Analgesic agent and its use

Publications (3)

Publication Number Publication Date
NO961479D0 NO961479D0 (no) 1996-04-12
NO961479L true NO961479L (no) 1996-06-11
NO308508B1 NO308508B1 (no) 2000-09-25

Family

ID=26303667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961479A NO308508B1 (no) 1993-10-13 1996-04-12 Anvendelse av levobupivacaine i enantiomert overskudd

Country Status (15)

Country Link
US (1) US5708011A (no)
EP (2) EP0727210B1 (no)
JP (2) JPH09503778A (no)
KR (1) KR100365979B1 (no)
CN (1) CN1074920C (no)
AT (2) ATE210982T1 (no)
AU (1) AU694453B2 (no)
DE (2) DE69429536T2 (no)
DK (2) DK0727210T3 (no)
ES (2) ES2101578T3 (no)
GR (1) GR3023289T3 (no)
HK (1) HK1006420A1 (no)
NO (1) NO308508B1 (no)
PT (1) PT727210E (no)
WO (1) WO1995010277A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
GB9507677D0 (en) * 1995-04-13 1995-05-31 Chiroscience Ltd Pharmaceutical formulation and dose
WO1996032109A2 (en) * 1995-04-13 1996-10-17 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women
GB9704351D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704370D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
BR9802536A (pt) * 1997-07-21 1999-07-20 Darwin Discovery Ltd Método para anestesiar um paciente humano antes de cirurgias
AU739510B2 (en) * 1997-07-22 2001-10-11 Darwin Discovery Limited Levobupivacaine and its use
DK1014946T3 (da) 1997-09-18 2010-06-28 Pacira Pharmaceuticals Inc Liposomale anæstetiske sammensætninger med forsinket frigivelse
JP4575592B2 (ja) 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
JP2001522888A (ja) * 1997-11-19 2001-11-20 ダーウィン・ディスカバリー・リミテッド 麻酔用製剤
NZ509186A (en) 1998-07-17 2005-01-28 Skyepharma Inc Biodegradable compositions for the controlled release of encapsulated substances
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
AU2002322024B2 (en) * 2001-05-31 2008-05-08 Pacira Pharmaceuticals, Inc. Encapsulation of nanosuspensions in liposomes and microspheres
US7829109B2 (en) * 2001-11-14 2010-11-09 Durect Corporation Catheter injectable depot compositions and uses thereof
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
WO2003041684A2 (en) * 2001-11-14 2003-05-22 Alza Corporation Injectable depot compositions and uses thereof
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP1526835B1 (en) * 2002-07-31 2008-04-23 ALZA Corporation Injectable depot compositions and uses thereof
JP4639400B2 (ja) * 2002-07-31 2011-02-23 デュレクト コーポレイション 注入可能な多モードポリマーのデポ組成物及びその使用
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US9226918B2 (en) * 2008-12-04 2016-01-05 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating or preventing narcotic withdrawal symptoms
EP3079668A1 (en) 2013-12-09 2016-10-19 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
CN106214670B (zh) * 2016-07-25 2020-12-29 上海璃道医药科技有限公司 酰胺类药物的用途
EP4090353A4 (en) 2020-01-13 2023-08-09 Durect Corporation REDUCED IMPURITY EXTENDED-RELEASE DRUG DELIVERY SYSTEMS AND METHODS
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
WO1996032109A2 (en) * 1995-04-13 1996-10-17 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Also Published As

Publication number Publication date
JP2006213736A (ja) 2006-08-17
EP0727210A3 (en) 1998-03-04
DE69429536D1 (de) 2002-01-31
GR3023289T3 (en) 1997-07-30
DK0723445T3 (da) 1997-10-06
EP0727210A2 (en) 1996-08-21
EP0723445B1 (en) 1997-03-26
NO308508B1 (no) 2000-09-25
CN1074920C (zh) 2001-11-21
WO1995010277A1 (en) 1995-04-20
AU7859494A (en) 1995-05-04
DE69402330T2 (de) 1997-07-03
ES2101578T3 (es) 1997-07-01
EP0727210B1 (en) 2001-12-19
DE69402330D1 (de) 1997-04-30
HK1006420A1 (en) 1999-02-26
JPH09503778A (ja) 1997-04-15
ATE150643T1 (de) 1997-04-15
PT727210E (pt) 2002-06-28
AU694453B2 (en) 1998-07-23
ES2170179T3 (es) 2002-08-01
US5708011A (en) 1998-01-13
DK0727210T3 (da) 2002-04-15
CN1133010A (zh) 1996-10-09
KR100365979B1 (ko) 2003-07-22
ATE210982T1 (de) 2002-01-15
DE69429536T2 (de) 2002-06-20
NO961479D0 (no) 1996-04-12
EP0723445A1 (en) 1996-07-31

Similar Documents

Publication Publication Date Title
NO961479D0 (no) Analgetisk middel og dets anvendelse
DK0396404T3 (da) Farmaceutisk middel indeholdende loratadin, ibuprofen og pseudoephedrin
DK609689A (da) Folielaminat og dets anvendelse
DK132689A (da) Oralt antitandstensmiddel og dets anvendelse
ATE127342T1 (de) Verwendung von modafinil zur herstellung eines antiischämischen arzneimittels.
DK721388A (da) Harpiksbindemiddel og dets anvendelse
DE69005010D1 (de) Einrichtung zur Sprachkodierung und -Dekodierung.
GB9704351D0 (en) Levobupivacaine and its use
NO974708L (no) Levobupivacain og dets anvendelse som anestetikum i gravide kvinner
DK455089D0 (da) Fremkaldermiddel og dets anvendelse
ES2095578T3 (es) Composicion para el tratamiento de mastitis y metritis.
NO932224L (no) Pleiemiddel for haarde og myke kontaktlinser
NO954207D0 (no) Preparat inneholdende kolestyramin og fremgangsmåte for dets fremstilling
DK425189D0 (da) Bloedgjort polyvinylalkoholslipmateriale og dets anvendelse
DK428189A (da) Brandhaemmende middel og dets anvendelse
DE69129131D1 (de) Einrichtung zur Sprachcodierung und Verwandte Decodierungseinrichtung
NO953846L (no) (S)-alfa-fenyl-2-pyridinetanamin (S)-malat og dets anvendelse som legemiddel
NO970185D0 (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
NO932315D0 (no) Overflateaktivt middel, fremgangsmaate ved dets fremstilling og anvendelse
DK162086A (da) Laegemiddel indeholdende vaevs-plasminogenaktivator, dets fremstilling og anvendelse
NO953847L (no) (5)-alfafenyl-2-pyridinetanaminbenzoat og dets anvendelse som legemiddel
ITFE920014U1 (it) Bisturi da utilizzare in chirurgia miniinvasia videoassistita
NO920063D0 (no) Farmasoeytisk preparat og dets anvendelse

Legal Events

Date Code Title Description
MK1K Patent expired